[go: up one dir, main page]

WO2014096389A1 - Méthode d'identification de cellules produisant des anticorps - Google Patents

Méthode d'identification de cellules produisant des anticorps Download PDF

Info

Publication number
WO2014096389A1
WO2014096389A1 PCT/EP2013/077757 EP2013077757W WO2014096389A1 WO 2014096389 A1 WO2014096389 A1 WO 2014096389A1 EP 2013077757 W EP2013077757 W EP 2013077757W WO 2014096389 A1 WO2014096389 A1 WO 2014096389A1
Authority
WO
WIPO (PCT)
Prior art keywords
cells
antigen
population
cell
labels
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2013/077757
Other languages
English (en)
Inventor
Daniel John Lightwood
Stephen Edward Rapecki
Dale Owen STARKIE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SA filed Critical UCB SA
Publication of WO2014096389A1 publication Critical patent/WO2014096389A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Definitions

  • the IgG marker for use in step a), is a mixture of two or more IgG markers for different isotypes.
  • the IgG marker is a mixture of anti-IgGl , anti-IgG2A and anti-IgG2B.
  • the method according to the present disclosure further comprises the step of identifying a B cell in the population employing a functional assay.
  • Identification of antibody secreting cells may be identified using a functional screening assay, for example a binding assay or measuring a functional effect such as neutralisation of a given activity.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne une méthode d'identification d'une cellule produisant un anticorps spécifique d'un antigène cible comprenant les étapes suivantes : a) fournir une population de lymphocytes B produisant un anticorps, ladite population ayant été sélectionnée en fonction d'au moins un marqueur de lymphocyte B et/ou au moins un marqueur sélectionné dans le groupe constitué d'un marqueur IgG, IgE et IgA et d'au moins deux marqueurs de « dé-sélection » (non présents sur le lymphocyte B cible), b) incuber la population de lymphocytes B de l'étape a) avec ledit antigène cible et au moins deux indicateurs distincts dudit antigène de façon que l'antigène soit dans une forme indiquée avec un premier indicateur et/ou un deuxième indicateur, c) sélectionner dans la population de cellules les cellules capables de produire des anticorps spécifiques de l'antigène cible, les cellules intéressantes étant identifiées grâce à au moins un de chacun desdits deux indicateurs, et d) sélectionner la population à multiples indications d'antigènes des cellules identifiées dans l'étape c), et e) facultativement, séparer la population des cellules sélectionnées dans l'étape d) en cellules uniques.
PCT/EP2013/077757 2012-12-21 2013-12-20 Méthode d'identification de cellules produisant des anticorps Ceased WO2014096389A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201223316A GB201223316D0 (en) 2012-12-21 2012-12-21 Method
GB1223316.9 2012-12-21

Publications (1)

Publication Number Publication Date
WO2014096389A1 true WO2014096389A1 (fr) 2014-06-26

Family

ID=47682527

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2013/077757 Ceased WO2014096389A1 (fr) 2012-12-21 2013-12-20 Méthode d'identification de cellules produisant des anticorps

Country Status (2)

Country Link
GB (1) GB201223316D0 (fr)
WO (1) WO2014096389A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108732082A (zh) * 2018-06-07 2018-11-02 北京唯公医疗技术有限公司 细胞分群方法
JP2021120679A (ja) * 2017-01-18 2021-08-19 エッセン インストラメンツ，インコーポレイテッド ディー／ビー／エー エッセン バイオサイエンス，インコーポレイテッド 生物学的サンプルから免疫グロブリンγ（ＩｇＧ）抗体アイソタイプの濃度を決定するための方法および試薬
US12467094B2 (en) 2021-03-11 2025-11-11 IgGenix, Inc. Methods and systems for predicting allergic response

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018068A1 (fr) * 1992-03-09 1993-09-16 Tanox Biosystems, Inc. Procedes permettant de selectionner des lymphocytes b peu communs specifiques d'un antigene
WO2006072803A2 (fr) * 2005-01-10 2006-07-13 Medical Research Council Anticorps
WO2013030799A1 (fr) * 2011-09-02 2013-03-07 Novartis Ag. Dosage de cellule b

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018068A1 (fr) * 1992-03-09 1993-09-16 Tanox Biosystems, Inc. Procedes permettant de selectionner des lymphocytes b peu communs specifiques d'un antigene
WO2006072803A2 (fr) * 2005-01-10 2006-07-13 Medical Research Council Anticorps
WO2013030799A1 (fr) * 2011-09-02 2013-03-07 Novartis Ag. Dosage de cellule b

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TOWNSEND S E ET AL: "Single epitope multiple staining to detect ultralow frequency B cells", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 249, no. 1-2, 1 March 2001 (2001-03-01), pages 137 - 146, XP004317478, ISSN: 0022-1759, DOI: 10.1016/S0022-1759(00)00352-5 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021120679A (ja) * 2017-01-18 2021-08-19 エッセン インストラメンツ，インコーポレイテッド ディー／ビー／エー エッセン バイオサイエンス，インコーポレイテッド 生物学的サンプルから免疫グロブリンγ（ＩｇＧ）抗体アイソタイプの濃度を決定するための方法および試薬
JP7170782B2 (ja) 2017-01-18 2022-11-14 ザルトリウス バイオアナリティカル インストゥルメンツ， インコーポレイテッド 生物学的サンプルから免疫グロブリンγ（ＩｇＧ）抗体アイソタイプの濃度を決定するための方法および試薬
US11733237B2 (en) 2017-01-18 2023-08-22 Sartorius Bioanalytical Instruments, Inc. Methods and reagents for determining immunoglobulin gamma (IgG) antibody isotype concentration from biological samples
CN108732082A (zh) * 2018-06-07 2018-11-02 北京唯公医疗技术有限公司 细胞分群方法
US12467094B2 (en) 2021-03-11 2025-11-11 IgGenix, Inc. Methods and systems for predicting allergic response

Also Published As

Publication number Publication date
GB201223316D0 (en) 2013-02-06

Similar Documents

Publication Publication Date Title
Sharma et al. Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma
US10175249B2 (en) Proteomic identification of antibodies
EP2972330A2 (fr) Protocole d'identification et d'isolement de lymphocytes b spécifiques d'un antigène et et production d'anticorps dirigés contre des antigènes souhaités
JP7687572B2 (ja) マルチパラメータサイトメトリーに基づく白血球サブセット化の為の手段及び方法
JP2012518390A5 (fr)
JP2017505436A5 (fr)
WO2009103753A1 (fr) Procédés d'identification et/ou de tri de cellules par molécule sécrétée et coffrets pour la mise en œuvre de tels procédés
US20140199319A1 (en) Methods for increasing the efficiency of hybridoma generation
WO2014096389A1 (fr) Méthode d'identification de cellules produisant des anticorps
EP1800133A1 (fr) Procedes de criblage de banques d'anticorps
US20220154174A1 (en) Method of Selecting for Antibodies
EP3674712A1 (fr) Méthodes et réactifs pour déterminer la concentration en isotype d'anticorps d'immunoglobuline g dans des échantillons biologiques
US20220049285A1 (en) Single cell/exosome/vesicle protein profiling
Shi et al. Co-staining human PBMCs with fluorescent antibodies and antibody-oligonucleotide conjugates for cell sorting prior to single-cell CITE-Seq
US20220034902A1 (en) Method for identifying high affinity monoclonal antibody heavy and light chain pairs from high throughput screens of b-cell and hybridoma libraries
Ferrara et al. Specific binder for Lightning-Link® biotinylated proteins from an antibody phage library
US20250003973A1 (en) Synthetic constructs and methods for processing antigen-specific cells
US20240003900A1 (en) Methods for producing antibodies
CN119876016A (zh) 一种兔单b细胞富集方法及微流控筛选方法
Dahan et al. Antibody‐based Proteomics: From bench to bedside
Wu Two magnetic enrichment methods for pancreatic circulating tumour cells detection
Hu et al. AAB-seq: An antigen-specific and affinity-readable high-throughput BCR sequencing method
HK40085879A (en) Methods for producing antibodies
RU2024135877A (ru) Способы селекции антител, специфичных в отношении комплексных мембранных антигенов
EP4605133A1 (fr) Moyens et procédés de découverte d'anticorps

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13815505

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13815505

Country of ref document: EP

Kind code of ref document: A1